DRAM (NT) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-DRAM (NT) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityDRAM (NT)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formatpeptide affinity purified
Size0.1 mg
Concentration1 mg/ml
ApplicationsWestern Blot (WB), Immunohistochemistry (IHC), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionBackground: Damage-regulated autophagy modulator (DRAM) is a p53 target gene encoding a lysosomal protein that induces autophagy, a process that degrades cytosolic proteins and organelles. It has been smuggested that activation of DRAM by p53 is simultaneous to the activation by p53 of one or more proapoptotic genes such as PUMA, Bax, etc., and that the signaling pathways regulated by these genes promote a full cell death response. By itself, DRAM cannot induce apoptosis, but the fact that it is inactivated in certain cancers highlights the importance of DRAM and smuggests that autophagy may play a more important role in cancer than initially suspected. At least two different isoforms of DRAM are known to exist.
ImmunogenImmunogen: DRAM antibody was raised against a 16 amino acid peptide from near the amino terminus of human DRAM. Positive Control: Western Blot: K562 cell lysateImmunohistochemistry: Human liver tissue
Other Names[Damage-regulated autophagy modulator], [DRAM1; DRAM1; DRAM; DRAM]
Gene, Accession #[DRAM], Gene ID: 55332, NCBI: NP_060840.2, UniProt: Q8N682
Catalog #MBS840905
Price$375
Order / More InfoDRAM (NT) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.